Decreased rates of transmission of drug-resistant HIV-1 strains containing the M184V mutation in reverse transcriptase

被引：0
|
作者：
Turner, D
Brenner, BG
Routy, JP
Moisi, D
Wainberg, MA
机构：
[1] McGill Univ, AIDS Ctr, Montreal, PQ, Canada
[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
129
引用
收藏
页码：U123 / U124
页数：2
相关论文
共 50 条
  • [41] Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine
    Murry, JP
    Higgins, J
    Matthews, TB
    Huang, VY
    Van Rompay, KKA
    Pedersen, NC
    North, TW
    JOURNAL OF VIROLOGY, 2003, 77 (02) : 1120 - 1130
  • [42] Entecavir therapy induces de novo HIV reverse-transcriptase M184V mutation in an antiretroviral therapy-naive patient
    Jakobsen, Martin R.
    Arildsen, Hanne
    Krarup, Henrik B.
    Tolstrup, Martin
    Ostergaard, Lars
    Laursen, Alex L.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (09) : E88 - E91
  • [43] New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T)
    Pouga, Lydia
    Santoro, Maria Mercedes
    Charpentier, Charlotte
    Di Carlo, Domenico
    Romeo, Isabella
    Artese, Anna
    Alcaro, Stefano
    Antinori, Andrea
    Wirden, Marc
    Perno, Carlo Federico
    Ambrosio, Francesca Alessandra
    Calvez, Vincent
    Descamps, Diane
    Marcelin, Anne-Genevieve
    Ceccherini-Silberstein, Francesca
    Lambert-Niclot, Sidonie
    CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (01) : 50 - 59
  • [44] Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1
    Hsu, ML
    Inouye, P
    Rezende, L
    Richard, N
    Li, Z
    Prasad, VR
    Wainberg, MA
    NUCLEIC ACIDS RESEARCH, 1997, 25 (22) : 4532 - 4536
  • [45] Estimation of the HIV-1 backward mutation rate from transmitted drug-resistant strains
    Kitayimbwa, J. M.
    Mugisha, J. Y. T.
    Saenz, R. A.
    THEORETICAL POPULATION BIOLOGY, 2016, 112 : 33 - 42
  • [46] Rationale for maintenance of the M184V resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients
    Turner, D
    Brenner, BG
    Routy, JP
    Petrella, M
    Wainberg, MA
    MICROBIOLOGICA, 2004, 27 (02): : 31 - 39
  • [47] Infrequent transmission of HIV-1 drug-resistant variants
    Yerly, S
    Jost, S
    Telenti, A
    Flepp, M
    Kaiser, L
    Chave, JP
    Vernazza, P
    Battegay, M
    Furrer, H
    Chanzy, B
    Burgisser, P
    Rickenbach, M
    Gebhardt, M
    Bernard, MC
    Perneger, T
    Hirschel, B
    Perrin, L
    ANTIVIRAL THERAPY, 2004, 9 (03) : 375 - 384
  • [48] Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe
    Vercauteren, Jurgen
    Wensing, Annemarie M. J.
    van de Vijver, David A. M. C.
    Albert, Jan
    Balotta, Claudia
    Hamouda, Osamah
    Kuecherer, Claudia
    Struck, Daniel
    Schmit, Jean-Claude
    Asjo, Birgitta
    Bruckova, Marie
    Camacho, Ricardo J.
    Clotet, Bonaventura
    Coughlan, Suzie
    Grossman, Zehava
    Horban, Andrzej
    Korn, Klaus
    Kostrikis, Leondios
    Nielsen, Claus
    Paraskevis, Dimitrios
    Poljak, Mario
    Puchhammer-Stoeckl, Elisabeth
    Riva, Chiara
    Ruiz, Lidia
    Salminen, Mika
    Schuurman, Rob
    Sonnerborg, Anders
    Stanekova, Danica
    Stanojevic, Maja
    Vandamme, Anne-Mieke
    Boucher, Charles A. B.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (10): : 1503 - 1508
  • [49] The impact of the HIV reverse transcriptase M184V mutation in combination with single thymidine analogue mutations on nucleoside reverse transcriptase inhibitor resistance in clinical samples from a large patient database
    Ross, L
    Parkin, N
    Bates, M
    Fisher, R
    St Clair, M
    Tisdale, M
    Lanier, R
    ANTIVIRAL THERAPY, 2003, 8 (03) : U134 - U135
  • [50] APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro
    Pereira, CF
    Paridaen, JTML
    van de Bovenkamp, M
    Middel, J
    Verhoef, J
    Nottet, HSLM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (05) : 1181 - 1189
12345